Anne Nagengast Johnson

Insider Reports History

Entity
Individual
Location
C/O Atai Life Sciences N.V., Wallstrasse 16, Berlin, Germany
Signature
/s/ Ryan Barrett, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Nagengast Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ATAI Life Sciences N.V. Chief Financial Officer Common Shares 140K $189K $1.35 Mar 21, 2025 Direct
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 758K Mar 3, 2025 Direct
ATAI Life Sciences N.V. Chief Financial Officer Restricted Stock Units 0 Mar 14, 2025 Direct

Insider Reports Filed by Anne Nagengast Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATAI ATAI Life Sciences N.V. Mar 21, 2025 1 -$45.3K 4 Mar 24, 2025 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Mar 14, 2025 2 $0 4 Mar 19, 2025 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Mar 3, 2025 1 $0 4 Mar 5, 2025 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Oct 4, 2024 4 $0 4 Oct 4, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Apr 2, 2024 1 -$50.7K 4 Apr 4, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Mar 13, 2024 3 $0 4 Mar 15, 2024 Chief Financial Officer
ATAI ATAI Life Sciences N.V. May 10, 2023 0 $0 3 May 19, 2023 Chief Accounting Officer